ArticleCancers2020

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.

Jean Camille Mattei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.